Eleven stories up, in the heart of New York City's fashion district, on a floor shared with a clothing designer, there's not an inch to squeeze another cubicle into ProteoMetrics' 17-person headquarters.

"We thought we would grow in a wise way within our means," says company chairman Brian Chait. But that is no longer an option for the software vendor, which got its start four years ago with an NIH small- business grant. Where there's a trend, there is often a crowd.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.